6adr
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<SX load='6adr' size='340' side='right' viewer='molstar' caption='[[6adr]], [[Resolution|resolution]] 3.38Å' scene=''> | <SX load='6adr' size='340' side='right' viewer='molstar' caption='[[6adr]], [[Resolution|resolution]] 3.38Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6adr]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[6adr]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Senecavirus_A Senecavirus A]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6ADR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6ADR FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.38Å</td></tr> |
- | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6adr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6adr OCA], [https://pdbe.org/6adr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6adr RCSB], [https://www.ebi.ac.uk/pdbsum/6adr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6adr ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6adr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6adr OCA], [https://pdbe.org/6adr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6adr RCSB], [https://www.ebi.ac.uk/pdbsum/6adr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6adr ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
- | + | [https://www.uniprot.org/uniprot/ANTR1_HUMAN ANTR1_HUMAN] Defects in ANTXR1 are associated with susceptibility to hemangioma capillary infantile (HCI) [MIM:[https://omim.org/entry/602089 602089]. HCI are benign, highly proliferative lesions involving aberrant localized growth of capillary endothelium. They are the most common tumor of infancy, occurring in up to 10% of all births. Hemangiomas tend to appear shortly after birth and show rapid neonatal growth for up to 12 months characterized by endothelial hypercellularity and increased numbers of mast cells. This phase is followed by slow involution at a rate of about 10% per year and replacement by fibrofatty stroma.<ref>PMID:18931684</ref> | |
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/ANTR1_HUMAN ANTR1_HUMAN] Plays a role in cell attachment and migration. Interacts with extracellular matrix proteins and with the actin cytoskeleton. Mediates adhesion of cells to type 1 collagen and gelatin, reorganization of the actin cytoskeleton and promotes cell spreading. Plays a role in the angiogenic response of cultured umbilical vein endothelial cells.<ref>PMID:15777794</ref> <ref>PMID:16762926</ref> | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 25: | Line 25: | ||
__TOC__ | __TOC__ | ||
</SX> | </SX> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: | + | [[Category: Senecavirus A]] |
- | [[Category: Cao | + | [[Category: Cao L]] |
- | [[Category: Lou | + | [[Category: Lou ZY]] |
- | + |
Current revision
Anthrax Toxin Receptor 1-bound the Seneca Valley Virus in neutral conditions
|